Difficulty: Medium
Average Score: 72%
Practice
Pralidoxime is a cholinesterase reactivator used in treatment of toxicity by:
Correct answer
C
Rationale
In the context of drugs and the peripheral nervous system, it is crucial to understand the mechanism of action of Pralidoxime and its role in treating toxicity. Pralidoxime is a cholinesterase reactivator used specifically in the treatment of toxicity caused by organophosphates, which are commonly found in pesticides and nerve agents.
The correct answer is C) Organic phosphate, which refers to organophosphates. Organophosphates inhibit acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine. By inhibiting this enzyme, acetylcholine accumulates in the synaptic cleft leading to overstimulation of cholinergic receptors, resulting in symptoms of toxicity. Pralidoxime works by reactivating the inhibited acetylcholinesterase, thereby restoring its activity and reducing the levels of acetylcholine.
A) Atropine is used to block the muscarinic effects of excess acetylcholine but does not directly address the inhibition of acetylcholinesterase caused by organophosphates.
B) Nicotine and D) Amphetamine are not related to the mechanism of action of Pralidoxime in treating organophosphate toxicity.
Understanding the specific uses and mechanisms of action of drugs like Pralidoxime is crucial for healthcare professionals, particularly those working in emergency medicine, toxicology, or areas where exposure to organophosphates is a risk. This knowledge ensures appropriate and timely interventions to manage toxicity effectively and improve patient outcomes.
The correct answer is C) Organic phosphate, which refers to organophosphates. Organophosphates inhibit acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine. By inhibiting this enzyme, acetylcholine accumulates in the synaptic cleft leading to overstimulation of cholinergic receptors, resulting in symptoms of toxicity. Pralidoxime works by reactivating the inhibited acetylcholinesterase, thereby restoring its activity and reducing the levels of acetylcholine.
A) Atropine is used to block the muscarinic effects of excess acetylcholine but does not directly address the inhibition of acetylcholinesterase caused by organophosphates.
B) Nicotine and D) Amphetamine are not related to the mechanism of action of Pralidoxime in treating organophosphate toxicity.
Understanding the specific uses and mechanisms of action of drugs like Pralidoxime is crucial for healthcare professionals, particularly those working in emergency medicine, toxicology, or areas where exposure to organophosphates is a risk. This knowledge ensures appropriate and timely interventions to manage toxicity effectively and improve patient outcomes.